Bendazac is a non-steroidal anti-inflammatory drug (NSAID) primarily recognized for its ability to inhibit protein denaturation, a mechanism investigated in research regarding the management of inflammatory… Read more
Bendazac is a non-steroidal anti-inflammatory drug (NSAID) primarily recognized for its ability to inhibit protein denaturation, a mechanism investigated in research regarding the management of inflammatory conditions and cataracts. The Bendazac category includes the parent drug, its L-lysine salt, and stable isotope labelled compounds such as Bendazac-d7 and Bendazac-d7 L-lysine. These chemical materials serve as essential reference standards for pharmaceutical laboratories engaged in drug development and regulatory compliance. Researchers and analytical chemists utilize these specific derivatives for rigorous method validation, impurity profiling, and quality control testing of the active pharmaceutical ingredient. By providing consistent and reliable materials for analytical instrumentation, this collection supports precise identification and quantification of the drug and its related substances throughout the lifecycle of pharmaceutical analysis.